Literature DB >> 31862741

Introduction: Standards of Medical Care in Diabetes-2020.

.   

Abstract

Entities:  

Year:  2020        PMID： 31862741     DOI： 10.2337/dc20-Sint

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  63 in total

Review 1.  Individualized Therapy for Hypothyroidism: Is T4 Enough for Everyone?

Authors:  Matthew D Ettleson; Antonio C Bianco
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

2.  Associations between attainment of incentivised primary care indicators and emergency hospital admissions among type 2 diabetes patients: a population-based historical cohort study.

Authors:  Laura H Gunn; Ailsa J McKay; Mariam Molokhia; Jonathan Valabhji; German Molina; Azeem Majeed; Eszter P Vamos
Journal:  J R Soc Med       Date:  2021-04-06       Impact factor: 5.344

3.  MicroRNAs and Risk Factors for Diabetic Nephropathy in Egyptian Children and Adolescents with Type 1 Diabetes.

Authors:  Shereen Abdelghaffar; Hassan Shora; Sahar Abdelatty; Fatma Elmougy; Reham El Sayed; Heba Abdelrahman; Hend Soliman; HebatAllah Algebaly; Sakinatalfouad Ahmed; Peter Alfy; Yasmine Elshiwy
Journal:  Diabetes Metab Syndr Obes       Date:  2020-07-13       Impact factor: 3.168

4.  Glycemic Control and the Risk of Acute Kidney Injury in Patients With Type 2 Diabetes and Chronic Kidney Disease: Parallel Population-Based Cohort Studies in U.S. and Swedish Routine Care.

Authors:  Yang Xu; Aditya Surapaneni; Jim Alkas; Marie Evans; Jung-Im Shin; Elizabeth Selvin; Alex Chang; Morgan E Grams; Juan Jesus Carrero
Journal:  Diabetes Care       Date:  2020-10-06       Impact factor: 19.112

Review 5.  Decision Algorithm for Prescribing SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease.

Authors:  Jiahua Li; Oltjon Albajrami; Min Zhuo; Chelsea E Hawley; Julie M Paik
Journal:  Clin J Am Soc Nephrol       Date:  2020-06-09       Impact factor: 8.237

6.  2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee.

Authors:  Sandeep R Das; Brendan M Everett; Kim K Birtcher; Jenifer M Brown; James L Januzzi; Rita R Kalyani; Mikhail Kosiborod; Melissa Magwire; Pamela B Morris; Joshua J Neumiller; Laurence S Sperling
Journal:  J Am Coll Cardiol       Date:  2020-08-05       Impact factor: 24.094

7.  (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.

Authors:  Thomas Semlitsch; Jennifer Engler; Andrea Siebenhofer; Klaus Jeitler; Andrea Berghold; Karl Horvath
Journal:  Cochrane Database Syst Rev       Date:  2020-11-09

8.  Adverse Events of Sodium-Glucose Cotransporter-2 Inhibitors in Chronic Kidney Disease: A Retrospective Chart Review.

Authors:  Hanul Choi; Leigh-Anh Nguyen; Jenny Wan; Hooman Milani; Kristine McGill; Jong Park
Journal:  Perm J       Date:  2021-05

9.  Glycaemic markers and all-cause mortality in older adults with and without diabetes: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Mary R Rooney; Olive Tang; James S Pankow; Elizabeth Selvin
Journal:  Diabetologia       Date:  2020-09-29       Impact factor: 10.122

10.  Analysis of patient-specific factors contributing to effectiveness of glucagon-like peptide-1 receptor agonists.

Authors:  Kelly A Mazzei; Ashley N Trippett; Teresa D Hedrick; Sijin Wen
Journal:  J Am Pharm Assoc (2003)       Date:  2020-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.